Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1843 1
1845 1
1846 1
1851 1
1856 1
1857 1
1858 2
1866 1
1869 1
1871 1
1872 1
1873 1
1877 1
1881 1
1893 1
1913 1
1938 1
1945 1
1946 1
1947 1
1948 7
1949 4
1950 5
1951 4
1952 6
1953 2
1954 1
1955 3
1956 3
1957 8
1958 6
1959 8
1960 5
1961 10
1962 7
1963 9
1964 16
1965 11
1966 11
1967 12
1968 11
1969 16
1970 20
1971 22
1972 20
1973 11
1974 18
1975 12
1976 10
1977 11
1978 22
1979 17
1980 20
1981 39
1982 31
1983 45
1984 63
1985 51
1986 48
1987 62
1988 45
1989 48
1990 36
1991 54
1992 61
1993 52
1994 65
1995 43
1996 52
1997 61
1998 40
1999 42
2000 60
2001 58
2002 78
2003 71
2004 59
2005 78
2006 75
2007 84
2008 73
2009 94
2010 83
2011 103
2012 98
2013 102
2014 100
2015 95
2016 98
2017 83
2018 76
2019 104
2020 105
2021 101
2022 81
2023 90
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

3,144 results

Results by year

Filters applied: . Clear all
Page 1
Current trends in the treatment of HR+/HER2+ breast cancer.
Kay C, Martínez-Pérez C, Meehan J, Gray M, Webber V, Dixon JM, Turnbull AK. Kay C, et al. Among authors: dixon jm. Future Oncol. 2021 May;17(13):1665-1681. doi: 10.2217/fon-2020-0504. Epub 2021 Mar 17. Future Oncol. 2021. PMID: 33726508 Free article. Review.
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.
Cassetta L, Fragkogianni S, Sims AH, Swierczak A, Forrester LM, Zhang H, Soong DYH, Cotechini T, Anur P, Lin EY, Fidanza A, Lopez-Yrigoyen M, Millar MR, Urman A, Ai Z, Spellman PT, Hwang ES, Dixon JM, Wiechmann L, Coussens LM, Smith HO, Pollard JW. Cassetta L, et al. Among authors: dixon jm. Cancer Cell. 2019 Apr 15;35(4):588-602.e10. doi: 10.1016/j.ccell.2019.02.009. Epub 2019 Mar 28. Cancer Cell. 2019. PMID: 30930117 Free PMC article.
DNA methylation atlas of the mouse brain at single-cell resolution.
Liu H, Zhou J, Tian W, Luo C, Bartlett A, Aldridge A, Lucero J, Osteen JK, Nery JR, Chen H, Rivkin A, Castanon RG, Clock B, Li YE, Hou X, Poirion OB, Preissl S, Pinto-Duarte A, O'Connor C, Boggeman L, Fitzpatrick C, Nunn M, Mukamel EA, Zhang Z, Callaway EM, Ren B, Dixon JR, Behrens MM, Ecker JR. Liu H, et al. Among authors: dixon jr. Nature. 2021 Oct;598(7879):120-128. doi: 10.1038/s41586-020-03182-8. Epub 2021 Oct 6. Nature. 2021. PMID: 34616061 Free PMC article.
Structural variants drive context-dependent oncogene activation in cancer.
Xu Z, Lee DS, Chandran S, Le VT, Bump R, Yasis J, Dallarda S, Marcotte S, Clock B, Haghani N, Cho CY, Akdemir KC, Tyndale S, Futreal PA, McVicker G, Wahl GM, Dixon JR. Xu Z, et al. Among authors: dixon jr. Nature. 2022 Dec;612(7940):564-572. doi: 10.1038/s41586-022-05504-4. Epub 2022 Dec 7. Nature. 2022. PMID: 36477537 Free PMC article.
Oligodendrocyte precursor cells engulf synapses during circuit remodeling in mice.
Auguste YSS, Ferro A, Kahng JA, Xavier AM, Dixon JR, Vrudhula U, Nichitiu AS, Rosado D, Wee TL, Pedmale UV, Cheadle L. Auguste YSS, et al. Among authors: dixon jr. Nat Neurosci. 2022 Oct;25(10):1273-1278. doi: 10.1038/s41593-022-01170-x. Epub 2022 Sep 28. Nat Neurosci. 2022. PMID: 36171430 Free PMC article.
Single nucleus multi-omics identifies human cortical cell regulatory genome diversity.
Luo C, Liu H, Xie F, Armand EJ, Siletti K, Bakken TE, Fang R, Doyle WI, Stuart T, Hodge RD, Hu L, Wang BA, Zhang Z, Preissl S, Lee DS, Zhou J, Niu SY, Castanon R, Bartlett A, Rivkin A, Wang X, Lucero J, Nery JR, Davis DA, Mash DC, Satija R, Dixon JR, Linnarsson S, Lein E, Behrens MM, Ren B, Mukamel EA, Ecker JR. Luo C, et al. Among authors: dixon jr. Cell Genom. 2022 Mar 9;2(3):100107. doi: 10.1016/j.xgen.2022.100107. Cell Genom. 2022. PMID: 35419551 Free PMC article.
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster HS, Hiddemann W, Marcus R, Kimby E, Herold M, Sebban C, Gyan E, Foon K, Nielsen T, Vitolo U, Salles GA, Shi Q, Flowers CR. Casulo C, et al. Among authors: dixon jg. Blood. 2022 Mar 17;139(11):1684-1693. doi: 10.1182/blood.2020010263. Blood. 2022. PMID: 34614146 Free PMC article.
3,144 results